STAT3 and hepatocellular carcinoma: Furthermore, we proved that activation of the miR‐125b‐5p/STAT3 axis promoted the phosphorylation and hydrolysis of β‐Catenin, resulting in suppression of wnt/β‐Catenin pathway activity, which ultimately produced the aforementioned therapeutic effects on hepatoma cells.